triazoles has been researched along with Acquired Immune Deficiency Syndrome in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (39.53) | 18.7374 |
1990's | 6 (13.95) | 18.2507 |
2000's | 17 (39.53) | 29.6817 |
2010's | 3 (6.98) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agsalda, M; Chew, GM; Chow, DC; Hanks, N; Ho, E; Kallianpur, KJ; Nakamoto, B; Ndhlovu, LC; Paul, R; Shikuma, CM; Shiramizu, BT; Umaki, T; Zhang, G | 1 |
Ålenius, M; Antonsson, L; Cederfjäll, E; Esbjörnsson, J; Gisslen, M; Jansson, M; Karlsson, U; Ljungberg, B; Repits, J; Sabirsh, A | 1 |
Anderson, AM; Diazgranados, CA; Gongora, MC; Hidron, AI | 1 |
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P | 1 |
Lu, HZ; Shen, YZ; Wang, ZY | 1 |
Greenberg, RN; Martin, CA; Roberts, S | 1 |
Albougy, HA; Naidoo, S | 1 |
Hilhorst, MI; Kuijpers, TW; Scherpbier, HJ | 1 |
Armour, D; Dobbs, S; Dorr, P; Griffin, P; Irvine, B; Macartney, M; Mori, J; Napier, C; Perros, M; Price, D; Rickett, G; Smith-Burchnell, C; Stammen, B; Webster, R; Westby, M; Wood, A | 1 |
Al-Agha, OM; Mooty, M; Salarieh, A | 1 |
Carmichael, JK | 1 |
Brizendine, E; Connolly, P; Durkin, M; Goldman, M; Mann, P; McNicholas, PM; Patel, R; Smedema, M; Wheat, LJ | 1 |
D'Cruz, OJ; Uckun, FM | 1 |
Cohen, J | 1 |
Kalavsky, E; Krcmery, V; Liskova, A; Shahum, A | 1 |
Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB | 1 |
Valenti, WM | 1 |
Kadow, JF; Meanwell, NA | 1 |
Schlamm, HT; Supparatpinyo, K | 1 |
Givner, LB; Horn, CA; Peacock, JE; Pegram, PS; Washburn, RG | 1 |
Bastide, JM; Janbon, F; Le Guennec, R; Mallié, M; Pujol, C; Reynes, J | 1 |
Alchorne, MM; Fischman, O; Kaminski, SK; Palmeira, Mdo C; Porro, AM; Yoshioka, MC | 1 |
Diehl, V; Fätkenheuer, G; Hegener, P; Ruhnke, M; Troke, PF | 1 |
Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
Chambers, HF; Lee, BL; Padula, AM; Sande, MA; Täuber, MG | 1 |
Andriole, VT; Patterson, TF | 1 |
Antinori, S; Esposito, R; Foppa, CU | 1 |
Bille, J; Cajot, A; Chave, JP; Glauser, MP | 1 |
Dietrich, D | 1 |
Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M | 1 |
Keil, TU | 1 |
Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD | 1 |
Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D | 1 |
Bordi, E; Galgani, S; Leoni, GC; Narciso, P; Sette, P; Tozzi, V; Visco, G | 1 |
Clumeck, N; De Wit, S; Goossens, H; Weerts, D | 1 |
Byrne, WR; Wajszczuk, CP | 1 |
Walsh, TJ | 1 |
Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ | 1 |
Saunders, C; Sugar, AM | 1 |
Drouhet, E; Dupont, B | 2 |
5 review(s) available for triazoles and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
A systematic review of the management of oral candidiasis associated with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Comorbidity; HIV Infections; Humans; Practice Guidelines as Topic; Treatment Outcome; Triazoles | 2002 |
Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; Chemistry, Pharmaceutical; Drug Design; Drug Industry; HIV; HIV Reverse Transcriptase; Humans; Models, Chemical; Models, Molecular; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Thiazoles; Thymine; Triazoles | 2006 |
Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Anti-Inflammatory Agents; Arthritis, Rheumatoid; CCR5 Receptor Antagonists; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclohexanes; HIV Infections; Humans; Maraviroc; Receptors, CCR5; Structure-Activity Relationship; Triazoles | 2007 |
Current concepts in cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Immune Tolerance; Prognosis; Triazoles; Virulence | 1989 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
2 trial(s) available for triazoles and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Prospective Studies; Recurrence; Triazoles | 1989 |
Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Clinical Trials as Topic; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Triazoles | 1988 |
36 other study(ies) available for triazoles and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associa
Topics: Acquired Immunodeficiency Syndrome; Aged; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cognition; Cyclohexanes; Disease Management; Female; Gene Expression; GPI-Linked Proteins; HIV-1; Humans; Leukocyte Count; Male; Maraviroc; Middle Aged; Monocytes; Neuropsychological Tests; Receptors, CCR5; Receptors, IgG; Triazoles; Viral Load | 2014 |
Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency.
Topics: Acquired Immunodeficiency Syndrome; CCR5 Receptor Antagonists; Cyclohexanes; Drug Resistance, Viral; env Gene Products, Human Immunodeficiency Virus; HIV-1; Humans; Maraviroc; Mutation; Triazoles | 2016 |
Prolonged survival of a patient with AIDS and central nervous system aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Aspergillus fumigatus; Brain; Head; Humans; Male; Neuroaspergillosis; Pyrimidines; Radiography; Survival; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Liver failure in a child receiving highly active antiretroviral therapy and voriconazole.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Child; Fatal Outcome; Female; Humans; Infectious Disease Transmission, Vertical; Liver Failure; Pyrimidines; Triazoles; Voriconazole | 2003 |
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Biological Availability; CCR5 Receptor Antagonists; Cyclohexanes; Dogs; Drug Resistance, Viral; Drug Therapy, Combination; HeLa Cells; HIV-1; Humans; Male; Maraviroc; Membrane Fusion; Rats; Rats, Sprague-Dawley; Receptors, CCR5; Triazoles | 2005 |
A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Bone Marrow; Female; Fever of Unknown Origin; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Pyrimidines; Silver Staining; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Coccidioidomycosis in HIV-infected persons.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coccidioidomycosis; HIV-1; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amino Acid Substitution; Antifungal Agents; Binding Sites; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Mutation; Triazoles | 2006 |
Retrovirus meeting. Hope on new AIDS drugs, but breast-feeding strategy backfires.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Botswana; Bottle Feeding; Breast Feeding; Cyclohexanes; Developing Countries; Female; Food Contamination; HIV Fusion Inhibitors; HIV Integrase Inhibitors; Humans; Infant; Infant Formula; Infectious Disease Transmission, Vertical; Maraviroc; Triazoles | 2007 |
Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cambodia; Candida; Candidiasis, Oral; Child; Drug Resistance, Multiple, Fungal; Humans; Oropharynx; Pharyngeal Diseases; Pyrimidines; Saccharomyces; Triazoles; Voriconazole | 2007 |
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
New drugs offer options.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Anti-HIV Agents; Clinical Trials as Topic; Cyclohexanes; Humans; Maraviroc; Organic Chemicals; Pyrrolidinones; Raltegravir Potassium; Triazoles | 2007 |
Translational research: application to HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Animals; Anti-Retroviral Agents; CCR5 Receptor Antagonists; Child; Cyclohexanes; Drug Resistance, Viral; HIV-1; Humans; Maraviroc; Receptors, CCR5; Research; Triazoles | 2007 |
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole | 2007 |
Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candidiasis; Candidiasis, Oral; Child, Preschool; Drug Resistance, Microbial; Esophageal Diseases; Female; Humans; Male; Middle Aged; Triazoles | 1995 |
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Electrophoresis; Enzymes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1995 |
Disseminated dermatophytosis caused by Microsporum gypseum in two patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Dermatomycoses; Female; Hand Dermatoses; Humans; Male; Microsporum; Onychomycosis; Piperazines; Skin; Triazoles | 1997 |
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 1998 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
Oral SCH 39304 as primary, salvage, and maintenance therapy for cryptococcal meningitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antifungal Agents; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Triazoles; Zidovudine | 1992 |
Fluconazole for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Meningitis; Triazoles | 1989 |
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Pilot Projects; Triazoles | 1989 |
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningitis; Opportunistic Infections; Prognosis; Triazoles | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles | 1989 |
[AIDS fungus infections. Fluconazole--a new preparation in development].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Opportunistic Infections; Triazoles | 1989 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Humans; Male; Meningitis; Prostatic Diseases; Recurrence; Triazoles; Urine | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles | 1989 |
Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Triazoles | 1989 |
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Male; Pharyngeal Diseases; Triazoles | 1989 |
Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles | 1988 |
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis; Middle Aged; Pneumonia; Triazoles | 1988 |
Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Immunosuppression Therapy; Kidney Transplantation; Meningitis; Triazoles | 1988 |
Cryptococcal meningitis and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles | 1987 |